Form 4: Colgate-Palmolive Director Receives Stock Grants

Martina Hundmejean, a Director at Colgate-Palmolive, received stock grants and options on May 11, 2026, as part of the company's incentive compensation plan.

Summary

• Martina Hundmejean, a Director at Colgate-Palmolive, was granted 2,075 shares of common stock and 2,424 stock options on May 11, 2026.
• The stock grant was an annual award under the company's incentive compensation plan and was credited to a stock unit account.
• The stock options have an exercise price of $86.74 and vest in equal annual installments over three years, becoming fully exercisable on May 11, 2034.
• Following these transactions, Hundmejean beneficially owns 16,206 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine compensation for a director and does not contain new financial performance data or strategic shifts.

Positives

• Director Martina Hundmejean received an annual stock grant and stock options, indicating continued equity-based compensation and alignment with shareholder interests.
• The stock options are exercisable, providing potential future value to the director.

Future Outlook

The filing does not contain forward-looking statements or guidance. The stock options granted have a vesting schedule extending over three years, with full exercisability by May 11, 2034.

Industry Context

StockSavvy.ai notes that the issuance of stock grants and options to directors is a common practice in the consumer staples industry, designed to incentivize long-term performance and align executive interests with those of shareholders.

Stakeholder Impact

• Shareholders: The grants align director incentives with long-term company performance, potentially benefiting shareholders through motivated leadership.

Next Steps

• Martina Hundmejean's stock options will become exercisable in equal annual installments over three years.
• The stock grant is credited to a stock unit account.

Key Dates

Keywords

Colgate-Palmolive, Form 4, Director Compensation, Stock Grant, Stock Options, Beneficial Ownership, SEC Filing